Research output per year
Research output per year
Search results
-
2021
Baicalein is a novel TLR4-targeting therapeutics agent that inhibits TLR4/HIF-1α/VEGF signaling pathway in colorectal cancer
CHEN, M., Zhong, K., Tan, J., Meng, M. M., Liu, C. M., CHEN, B., HUANG, C., WONG, H. L. X., BIAN, Z., Su, T. & KWAN, H. Y., Nov 2021, In: Clinical and Translational Medicine. 11, 11, e564.Research output: Contribution to journal › Letter › peer-review
Open Access -
2014
Inhibition of STAT3 signalling contributes to the antimelanoma action of atractylenolide II
FU, X., Chou, G. X., KWAN, H. Y., TSE, A. K. W., Zhao, L. H., Yuen, T. K., Cao, H. H., Yu, H., Chao, X. J., Su, T., Cheng, B. C. Y., Sun, X. G. & YU, Z., 1 Nov 2014, In: Experimental Dermatology. 23, 11, p. 855-857 3 p.Research output: Contribution to journal › Letter › peer-review
Open Access25 Citations (Scopus)